Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donepezil and Memantine in Moderate to Severe Alzheimer's Disease
NCT00866060Phase 4Unknown
- Sponsor
- King's College London
- Start
- Feb 2008
- Primary completion
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of donepezil and memantine in Alzheimer's disease (AD), sponsored by King's College London. Status: unknown.
02
Drugs
donepezilmemantine
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00866060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00866060.